Wolverine Trading, LLC Sorrento Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $59,494 - $113,472	39,400 New	39,400 $62,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $41,540 - $78,055	-33,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $67,000 - $164,150	33,500 New	33,500 $79,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $732,375 - $1.14 Million	-157,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $71,136 - $105,504	9,600 Added 6.49%	157,500 $1.17 Million
Q2 2021 Aug 06, 2021	SELL	$6.35 - $10.0 $50,800 - $80,000	-8,000 Reduced 5.13%	147,900 $1.44 Million
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $139,194 - $326,898	-19,800 Reduced 11.27%	155,900 $1.25 Million
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $410,112 - $850,840	71,200 Added 68.13%	175,700 $1.27 Million
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $644,765 - $1.97 Million	104,500 New	104,500 $1.21 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.